Publication Date: October 2025
From fast follower to fast leader: My journey into China’s biotech boom
China’s biotech push is reshaping global pharma and challenging US scientific leadership. After a research trip to Shanghai, Franklin Equity Group’s Evan McCulloch highlights the implications for US and European biotech firms.
Client Use:
Yes
Literature Code:
FEG25-CHBIO
Format
PDF
